These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38889291)

  • 1. Clinical trial recruitment of people who speak languages other than English: a Children's Oncology Group report.
    Beauchemin MP; Ortega M; Santacroce SJ; Robles JM; Ruiz J; Hall AG; Kahn JM; Fu C; Orjuela-Grimm M; Hillyer GC; Solomon S; Pelletier W; Montiel-Esparza R; Blazin LJ; Kline C; Seif AE; Aristizabal P; Winestone LE; Velez MC
    JNCI Cancer Spectr; 2024 Jul; 8(4):. PubMed ID: 38889291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group.
    Santacroce SJ; Beauchemin MP; Pelletier W; Robles JM; Ruiz J; Blazin LJ; Aristizabal P; Orjuela-Grimm M; Hall AG; Kahn J; Kline C; Seif AE; Velez MC; Winestone LE
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31321. PubMed ID: 39238140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Discharge Instructions for Limited English-Proficient Families: Strategies and Barriers.
    Davis SH; Rosenberg J; Nguyen J; Jimenez M; Lion KC; Jenicek G; Dallmann H; Yun K
    Hosp Pediatr; 2019 Oct; 9(10):779-787. PubMed ID: 31562199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the language barriers to translating informed consent documents for maternal health trials in Zambia: a qualitative study.
    Beardmore-Gray A; Simwinga M; Vwalika B; Chinkoyo S; Chappell L; Sandall J; Shennan A
    BMJ Open; 2024 Apr; 14(4):e076744. PubMed ID: 38580359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    Muthukumar AV; Morrell W; Bierer BE
    PLoS Med; 2021 Sep; 18(9):e1003758. PubMed ID: 34520467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative consent for patients with limited English proficiency.
    Patel DN; Wakeam E; Genoff M; Mujawar I; Ashley SW; Diamond LC
    J Surg Res; 2016 Feb; 200(2):514-22. PubMed ID: 26541685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRB Policies for Obtaining Informed Consent from Non-English-Speaking People.
    McMillan G
    Ethics Hum Res; 2020 May; 42(3):21-29. PubMed ID: 32421949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should consent forms used in clinical trials be translated into the local dialects? A survey among past participants in rural Ghana.
    Baiden F; Akazili J; Chatio S; Achana FS; Oduro AR; Ravinetto R; Hodgson A
    Clin Trials; 2016 Apr; 13(2):234-9. PubMed ID: 26452387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Conduit for a Culturally Competent Consent: Medical Interpreters' Perspectives on Surgical Informed Consent Discussions.
    Allar BG; Ponce C; Wallace J; Ortega G; Reich AJ; Gold-Gomez S; Gangadharan SP; Kent TS
    Ann Surg; 2024 Jul; 280(1):66-74. PubMed ID: 37990875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Access to Professional Interpreters in the Hospital Improves Informed Consent for Patients with Limited English Proficiency.
    Lee JS; Pérez-Stable EJ; Gregorich SE; Crawford MH; Green A; Livaudais-Toman J; Karliner LS
    J Gen Intern Med; 2017 Aug; 32(8):863-870. PubMed ID: 28185201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of language barriers on documentation of informed consent at a hospital with on-site interpreter services.
    Schenker Y; Wang F; Selig SJ; Ng R; Fernandez A
    J Gen Intern Med; 2007 Nov; 22 Suppl 2(Suppl 2):294-9. PubMed ID: 17957414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The informed consent process in a cross-cultural setting: is the process achieving the intended result?
    McCabe M; Morgan F; Curley H; Begay R; Gohdes DM
    Ethn Dis; 2005; 15(2):300-4. PubMed ID: 15825977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An absence of translated consent forms limits oncologic clinical trial enrollment for limited English proficiency participants.
    Guo XM; Neuman MK; Vallejo A; Matsuo K; Roman LD
    Gynecol Oncol; 2024 Jan; 180():86-90. PubMed ID: 38061275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group.
    Terao M; Mittal N; Roth M; Saha A; Super L; Reichek J
    J Adolesc Young Adult Oncol; 2024 Feb; 13(1):132-137. PubMed ID: 37540127
    [No Abstract]   [Full Text] [Related]  

  • 18. Language Translation Apps in Health Care Settings: Expert Opinion.
    Panayiotou A; Gardner A; Williams S; Zucchi E; Mascitti-Meuter M; Goh AM; You E; Chong TW; Logiudice D; Lin X; Haralambous B; Batchelor F
    JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11316. PubMed ID: 30964446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient.
    Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG
    Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to the inclusion of deaf people in clinical trials.
    Kushalnagar P; Nicolarakis O; Mirus G; Anderson M; Burke T; Kushalnagar R
    Clin Trials; 2023 Oct; 20(5):576-580. PubMed ID: 37243366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.